Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension.

Bunclark K, Newnham M, Chiu YD, Ruggiero A, Villar SS, Cannon JE, Coghlan G, Corris PA, Howard L, Jenkins D, Johnson M, Kiely DG, Ng C, Screaton N, Sheares K, Taboada D, Tsui S, Wort SJ, Pepke-Zaba J, Toshner M.

J Thromb Haemost. 2019 Sep 26. doi: 10.1111/jth.14649. [Epub ahead of print]

PMID:
31557382
2.

Reply to Echocardiographic predictors of outcome in PAH.

McCabe C, Ivanac Vranesic I, Castro Verdes M, Kempny A, Khan U, Price L, Gatzoulis MA, Dimopoulos K, Wort SJ, Li W.

Int J Cardiol. 2019 Nov 1;294:58. doi: 10.1016/j.ijcard.2019.08.009. No abstract available.

PMID:
31522720
3.

A single-centre, placebo-controlled, double-blind randomised cross-over study of nebulised iloprost in patients with Eisenmenger syndrome: A pilot study.

Nashat H, Kempny A, Harries C, Dormand N, Alonso-Gonzalez R, Price LC, Gatzoulis MA, Dimopoulos K, Wort SJ.

Int J Cardiol. 2019 Jul 4. pii: S0167-5273(19)31450-0. doi: 10.1016/j.ijcard.2019.07.004. [Epub ahead of print]

PMID:
31371115
4.

Right Ventricular to Left Ventricular Ratio at CT Pulmonary Angiogram Predicts Mortality in Interstitial Lung Disease.

Bax S, Jacob J, Ahmed R, Bredy C, Dimopoulos K, Kempny A, Kokosi M, Kier G, Renzoni E, Molyneaux PL, Chua F, Kouranos V, George P, McCabe C, Wilde M, Devaraj A, Wells A, Wort SJ, Price LC.

Chest. 2019 Jul 24. pii: S0012-3692(19)31374-1. doi: 10.1016/j.chest.2019.06.033. [Epub ahead of print]

PMID:
31351047
5.

Chronic thromboembolic pulmonary hypertension following long-term peripherally inserted central venous catheter use.

Masding A, Preston SD, Toshner M, Barnett J, Harries C, Dimopoulos K, Kempny A, McCabe C, Jenkins DP, Wort SJ, Price LC.

Pulm Circ. 2019 Apr-Jun;9(2):2045894019859474. doi: 10.1177/2045894019859474.

6.

Right ventricular systolic to diastolic duration ratio: A novel predictor of outcome in adult idiopathic pulmonary arterial hypertension.

McCabe C, Vranesic II, Verdes MC, Kempny A, Khan U, Price L, Gatzoulis MA, Dimopoulos K, Wort SJ, Li W.

Int J Cardiol. 2019 Oct 15;293:218-222. doi: 10.1016/j.ijcard.2019.05.019. Epub 2019 May 8.

PMID:
31126734
7.

Eisenmenger syndrome and other types of pulmonary arterial hypertension related to adult congenital heart disease.

Favoccia C, Constantine AH, Wort SJ, Dimopoulos K.

Expert Rev Cardiovasc Ther. 2019 Jun;17(6):449-459. doi: 10.1080/14779072.2019.1623024. Epub 2019 Jun 6. Review.

PMID:
31120797
8.

Blood Viscosity and its Relevance to the Diagnosis and Management of Pulmonary Hypertension.

Kempny A, Dimopoulos K, Fraisse A, Diller GP, Price LC, Rafiq I, McCabe C, Gatzoulis MA, Wort SJ.

J Am Coll Cardiol. 2019 May 28;73(20):2640-2642. doi: 10.1016/j.jacc.2019.02.066. No abstract available.

9.

Early histological changes of pulmonary arterial hypertension disclosed by invasive cardiopulmonary exercise testing.

Bhatti YJ, Rice AJ, Kempny A, Dimopoulos K, Price LC, Ranu H, Wells A, Wort SJ, McCabe C.

Pulm Circ. 2019 Apr-Jun;9(2):2045894019845615. doi: 10.1177/2045894019845615.

10.

Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: a UK cohort study analysis.

Sofianopoulou E, Kaptoge S, Gräf S, Hadinnapola C, Treacy CM, Church C, Coghlan G, Gibbs JSR, Haimel M, Howard LS, Johnson M, Kiely DG, Lawrie A, Lordan J, MacKenzie Ross RV, Martin JM, Moledina S, Newnham M, Peacock AJ, Price LC, Rhodes CJ, Suntharalingam J, Swietlik EM, Toshner MR, Wharton J, Wilkins MR, Wort SJ, Pepke-Zaba J, Condliffe R, Corris PA, Di Angelantonio E, Provencher S, Morrell NW.

Eur Respir J. 2019 May 30;53(5). pii: 1801429. doi: 10.1183/13993003.01429-2018. Print 2019 May.

PMID:
30923185
11.

Tumoral pulmonary hypertension.

Price LC, Seckl MJ, Dorfmüller P, Wort SJ.

Eur Respir Rev. 2019 Feb 6;28(151). pii: 180065. doi: 10.1183/16000617.0065-2018. Print 2019 Mar 31. Review.

12.

Machine learning algorithms estimating prognosis and guiding therapy in adult congenital heart disease: data from a single tertiary centre including 10 019 patients.

Diller GP, Kempny A, Babu-Narayan SV, Henrichs M, Brida M, Uebing A, Lammers AE, Baumgartner H, Li W, Wort SJ, Dimopoulos K, Gatzoulis MA.

Eur Heart J. 2019 Apr 1;40(13):1069-1077. doi: 10.1093/eurheartj/ehy915.

PMID:
30689812
13.

Heart or heart-lung transplantation for patients with congenital heart disease in England.

Dimopoulos K, Muthiah K, Alonso-Gonzalez R, Banner NR, Wort SJ, Swan L, Constantine AH, Gatzoulis MA, Diller GP, Kempny A.

Heart. 2019 Apr;105(8):596-602. doi: 10.1136/heartjnl-2018-313984. Epub 2019 Jan 12.

14.

EmPHasis-10 score for the assessment of quality of life in various types of pulmonary hypertension and its relation to outcome.

Favoccia C, Kempny A, Yorke J, Armstrong I, Price LC, McCabe C, Harries C, Wort SJ, Dimopoulos K.

Eur J Prev Cardiol. 2019 Aug;26(12):1338-1340. doi: 10.1177/2047487318819161. Epub 2018 Dec 19. No abstract available.

PMID:
30567456
15.

Growth/differentiation factor 15 causes TGFβ-activated kinase 1-dependent muscle atrophy in pulmonary arterial hypertension.

Garfield BE, Crosby A, Shao D, Yang P, Read C, Sawiak S, Moore S, Parfitt L, Harries C, Rice M, Paul R, Ormiston ML, Morrell NW, Polkey MI, Wort SJ, Kemp PR.

Thorax. 2019 Feb;74(2):164-176. doi: 10.1136/thoraxjnl-2017-211440. Epub 2018 Dec 15.

16.

Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis.

Rhodes CJ, Batai K, Bleda M, Haimel M, Southgate L, Germain M, Pauciulo MW, Hadinnapola C, Aman J, Girerd B, Arora A, Knight J, Hanscombe KB, Karnes JH, Kaakinen M, Gall H, Ulrich A, Harbaum L, Cebola I, Ferrer J, Lutz K, Swietlik EM, Ahmad F, Amouyel P, Archer SL, Argula R, Austin ED, Badesch D, Bakshi S, Barnett C, Benza R, Bhatt N, Bogaard HJ, Burger CD, Chakinala M, Church C, Coghlan JG, Condliffe R, Corris PA, Danesino C, Debette S, Elliott CG, Elwing J, Eyries M, Fortin T, Franke A, Frantz RP, Frost A, Garcia JGN, Ghio S, Ghofrani HA, Gibbs JSR, Harley J, He H, Hill NS, Hirsch R, Houweling AC, Howard LS, Ivy D, Kiely DG, Klinger J, Kovacs G, Lahm T, Laudes M, Machado RD, MacKenzie Ross RV, Marsolo K, Martin LJ, Moledina S, Montani D, Nathan SD, Newnham M, Olschewski A, Olschewski H, Oudiz RJ, Ouwehand WH, Peacock AJ, Pepke-Zaba J, Rehman Z, Robbins I, Roden DM, Rosenzweig EB, Saydain G, Scelsi L, Schilz R, Seeger W, Shaffer CM, Simms RW, Simon M, Sitbon O, Suntharalingam J, Tang H, Tchourbanov AY, Thenappan T, Torres F, Toshner MR, Treacy CM, Vonk Noordegraaf A, Waisfisz Q, Walsworth AK, Walter RE, Wharton J, White RJ, Wilt J, Wort SJ, Yung D, Lawrie A, Humbert M, Soubrier F, Trégouët DA, Prokopenko I, Kittles R, Gräf S, Nichols WC, Trembath RC, Desai AA, Morrell NW, Wilkins MR; UK NIHR BioResource Rare Diseases Consortium; UK PAH Cohort Study Consortium; US PAH Biobank Consortium.

Lancet Respir Med. 2019 Mar;7(3):227-238. doi: 10.1016/S2213-2600(18)30409-0. Epub 2018 Dec 5.

17.

Echocardiographic Screening for Pulmonary Hypertension in Congenital Heart Disease: JACC Review Topic of the Week.

Dimopoulos K, Condliffe R, Tulloh RMR, Clift P, Alonso-Gonzalez R, Bedair R, Chung NAY, Coghlan G, Fitzsimmons S, Frigiola A, Howard LS, Jenkins P, Kenny D, Li W, MacDonald ST, McCabe C, Oliver JJ, Spence MS, Szantho GV, von Klemperer K, Wilson DG, Wort SJ; CHAMPION Steering Committee.

J Am Coll Cardiol. 2018 Dec 4;72(22):2778-2788. doi: 10.1016/j.jacc.2018.08.2201.

18.

Incidence, mortality and bleeding rates associated with pulmonary embolism in England between 1997 and 2015.

Kempny A, McCabe C, Dimopoulos K, Price LC, Wilde M, Limbrey R, Gatzoulis MA, Wort SJ.

Int J Cardiol. 2019 Feb 15;277:229-234. doi: 10.1016/j.ijcard.2018.10.001. Epub 2018 Oct 2.

PMID:
30448018
19.

Loss-of-Function ABCC8 Mutations in Pulmonary Arterial Hypertension.

Bohnen MS, Ma L, Zhu N, Qi H, McClenaghan C, Gonzaga-Jauregui C, Dewey FE, Overton JD, Reid JG, Shuldiner AR, Baras A, Sampson KJ, Bleda M, Hadinnapola C, Haimel M, Bogaard HJ, Church C, Coghlan G, Corris PA, Eyries M, Gibbs JSR, Girerd B, Houweling AC, Humbert M, Guignabert C, Kiely DG, Lawrie A, MacKenzie Ross RV, Martin JM, Montani D, Peacock AJ, Pepke-Zaba J, Soubrier F, Suntharalingam J, Toshner M, Treacy CM, Trembath RC, Vonk Noordegraaf A, Wharton J, Wilkins MR, Wort SJ, Yates K, Gräf S, Morrell NW, Krishnan U, Rosenzweig EB, Shen Y, Nichols CG, Kass RS, Chung WK.

Circ Genom Precis Med. 2018 Oct;11(10):e002087. doi: 10.1161/CIRCGEN.118.002087.

20.

Atrial septal defects and pulmonary arterial hypertension.

Nashat H, Montanaro C, Li W, Kempny A, Wort SJ, Dimopoulos K, Gatzoulis MA, Babu-Narayan SV.

J Thorac Dis. 2018 Sep;10(Suppl 24):S2953-S2965. doi: 10.21037/jtd.2018.08.92. Review.

21.

The Hepcidin/Ferroportin axis modulates proliferation of pulmonary artery smooth muscle cells.

Ramakrishnan L, Pedersen SL, Toe QK, West LE, Mumby S, Casbolt H, Issitt T, Garfield B, Lawrie A, Wort SJ, Quinlan GJ.

Sci Rep. 2018 Aug 28;8(1):12972. doi: 10.1038/s41598-018-31095-0.

22.

Pulmonary Arterial Hypertension: Iron Matters.

Ramakrishnan L, Pedersen SL, Toe QK, Quinlan GJ, Wort SJ.

Front Physiol. 2018 May 31;9:641. doi: 10.3389/fphys.2018.00641. eCollection 2018. Review.

23.

Use of intravenous iron in cyanotic patients with congenital heart disease and/or pulmonary hypertension.

Blanche C, Alonso-Gonzalez R, Uribarri A, Kempny A, Swan L, Price L, Wort SJ, Beghetti M, Dimopoulos K.

Int J Cardiol. 2018 Sep 15;267:79-83. doi: 10.1016/j.ijcard.2018.05.062. Epub 2018 May 19.

PMID:
29807779
24.

Arrhythmias in adult patients with congenital heart disease and pulmonary arterial hypertension.

Drakopoulou M, Nashat H, Kempny A, Alonso-Gonzalez R, Swan L, Wort SJ, Price LC, McCabe C, Wong T, Gatzoulis MA, Ernst S, Dimopoulos K.

Heart. 2018 Dec;104(23):1963-1969. doi: 10.1136/heartjnl-2017-312881. Epub 2018 May 18.

25.

A stepwise composite echocardiographic score predicts severe pulmonary hypertension in patients with interstitial lung disease.

Bax S, Bredy C, Kempny A, Dimopoulos K, Devaraj A, Walsh S, Jacob J, Nair A, Kokosi M, Keir G, Kouranos V, George PM, McCabe C, Wilde M, Wells A, Li W, Wort SJ, Price LC.

ERJ Open Res. 2018 May 4;4(2). pii: 00124-2017. doi: 10.1183/23120541.00124-2017. eCollection 2018 Apr. Erratum in: ERJ Open Res. 2018 Jul 31;4(3):.

26.

Balloon pulmonary angioplasty for chronic thromboembolic disease: aiming for perfection.

Kempny A, Wort SJ, Dimopoulos K.

EuroIntervention. 2018 Apr 20;13(17):1983-1986. doi: 10.4244/EIJV13I17A323. No abstract available.

27.

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension.

Gräf S, Haimel M, Bleda M, Hadinnapola C, Southgate L, Li W, Hodgson J, Liu B, Salmon RM, Southwood M, Machado RD, Martin JM, Treacy CM, Yates K, Daugherty LC, Shamardina O, Whitehorn D, Holden S, Aldred M, Bogaard HJ, Church C, Coghlan G, Condliffe R, Corris PA, Danesino C, Eyries M, Gall H, Ghio S, Ghofrani HA, Gibbs JSR, Girerd B, Houweling AC, Howard L, Humbert M, Kiely DG, Kovacs G, MacKenzie Ross RV, Moledina S, Montani D, Newnham M, Olschewski A, Olschewski H, Peacock AJ, Pepke-Zaba J, Prokopenko I, Rhodes CJ, Scelsi L, Seeger W, Soubrier F, Stein DF, Suntharalingam J, Swietlik EM, Toshner MR, van Heel DA, Vonk Noordegraaf A, Waisfisz Q, Wharton J, Wort SJ, Ouwehand WH, Soranzo N, Lawrie A, Upton PD, Wilkins MR, Trembath RC, Morrell NW.

Nat Commun. 2018 Apr 12;9(1):1416. doi: 10.1038/s41467-018-03672-4.

28.

miR-322-5p targets IGF-1 and is suppressed in the heart of rats with pulmonary hypertension.

Connolly M, Garfield BE, Crosby A, Morrell NW, Wort SJ, Kemp PR.

FEBS Open Bio. 2018 Jan 24;8(3):339-348. doi: 10.1002/2211-5463.12369. eCollection 2018 Mar.

29.

Year in review 2017: Interstitial lung disease, pulmonary vascular disease and sleep.

Piper AJ, Wort SJ, Renzoni EA, Kouranos V.

Respirology. 2018 Apr;23(4):421-433. doi: 10.1111/resp.13273. Epub 2018 Feb 22. Review. No abstract available.

30.

Pulmonary hypertension in interstitial lung disease: Limitations of echocardiography compared to cardiac catheterization.

Keir GJ, Wort SJ, Kokosi M, George PM, Walsh SLF, Jacob J, Price L, Bax S, Renzoni EA, Maher TM, MacDonald P, Hansell DM, Wells AU.

Respirology. 2018 Jul;23(7):687-694. doi: 10.1111/resp.13250. Epub 2018 Jan 12.

31.

miR-424-5p reduces ribosomal RNA and protein synthesis in muscle wasting.

Connolly M, Paul R, Farre-Garros R, Natanek SA, Bloch S, Lee J, Lorenzo JP, Patel H, Cooper C, Sayer AA, Wort SJ, Griffiths M, Polkey MI, Kemp PR.

J Cachexia Sarcopenia Muscle. 2018 Apr;9(2):400-416. doi: 10.1002/jcsm.12266. Epub 2017 Dec 7.

32.

British Thoracic Society Clinical Statement on Pulmonary Arteriovenous Malformations.

Shovlin CL, Condliffe R, Donaldson JW, Kiely DG, Wort SJ; British Thoracic Society.

Thorax. 2017 Dec;72(12):1154-1163. doi: 10.1136/thoraxjnl-2017-210764.

33.

Pulmonary arteriovenous malformations emerge from the shadows.

Shovlin CL, Condliffe R, Donaldson JW, Kiely DG, Wort SJ.

Thorax. 2017 Dec;72(12):1071-1073. doi: 10.1136/thoraxjnl-2017-211072. No abstract available.

34.

Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients.

Michelakis ED, Gurtu V, Webster L, Barnes G, Watson G, Howard L, Cupitt J, Paterson I, Thompson RB, Chow K, O'Regan DP, Zhao L, Wharton J, Kiely DG, Kinnaird A, Boukouris AE, White C, Nagendran J, Freed DH, Wort SJ, Gibbs JSR, Wilkins MR.

Sci Transl Med. 2017 Oct 25;9(413). pii: eaao4583. doi: 10.1126/scitranslmed.aao4583.

35.

Pulmonary Arterial Hypertension Complicating Congenital Heart Disease: Advances in Therapy.

Nashat H, Brida M, Price LS, McCabe C, Alonso-Gonzalez R, Wort SJ, Kempny A, Dimopoulos K, Gatzoulis MJ.

Semin Respir Crit Care Med. 2017 Oct;38(5):636-650. doi: 10.1055/s-0037-1606222. Epub 2017 Oct 15. Review. No abstract available.

PMID:
29032566
36.

Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension.

Hadinnapola C, Bleda M, Haimel M, Screaton N, Swift A, Dorfmüller P, Preston SD, Southwood M, Hernandez-Sanchez J, Martin J, Treacy C, Yates K, Bogaard H, Church C, Coghlan G, Condliffe R, Corris PA, Gibbs S, Girerd B, Holden S, Humbert M, Kiely DG, Lawrie A, Machado R, MacKenzie Ross R, Moledina S, Montani D, Newnham M, Peacock A, Pepke-Zaba J, Rayner-Matthews P, Shamardina O, Soubrier F, Southgate L, Suntharalingam J, Toshner M, Trembath R, Vonk Noordegraaf A, Wilkins MR, Wort SJ, Wharton J; NIHR BioResource–Rare Diseases Consortium; UK National Cohort Study of Idiopathic and Heritable PAH, Gräf S, Morrell NW.

Circulation. 2017 Nov 21;136(21):2022-2033. doi: 10.1161/CIRCULATIONAHA.117.028351. Epub 2017 Sep 28.

37.

The CRASH report: emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertension.

Price LC, Dimopoulos K, Marino P, Alonso-Gonzalez R, McCabe C, Kemnpy A, Swan L, Boutsikou M, Al Zahrani A, Coghlan GJ, Schreiber BE, Howard LS, Davies R, Toshner M, Pepke-Zaba J, Church AC, Peacock A, Corris PA, Lordan JL, Gaine S, Condliffe R, Kiely DG, Wort SJ.

Thorax. 2017 Nov;72(11):1035-1045. doi: 10.1136/thoraxjnl-2016-209725. Epub 2017 Sep 12. Review.

PMID:
28904006
38.

Response by Kempny et al to Letter Regarding Article, "Predictors of Death in Contemporary Adult Patients With Eisenmenger Syndrome: A Multicenter Study".

Kempny A, Sørensen Hjortshøj C, Li W, Schophuus Jensen A, Søndergaard L, Diller GP, Dimopoulos K, Wort SJ, Gatzoulis MA.

Circulation. 2017 Sep 12;136(11):1078-1079. doi: 10.1161/CIRCULATIONAHA.117.029768. No abstract available.

PMID:
28893965
39.

Platelet count and mean platelet volume predict outcome in adults with Eisenmenger syndrome.

Martin-Garcia AC, Arachchillage DR, Kempny A, Alonso-Gonzalez R, Martin-Garcia A, Uebing A, Swan L, Wort SJ, Price LC, McCabe C, Sanchez PL, Dimopoulos K, Gatzoulis MA.

Heart. 2018 Jan;104(1):45-50. doi: 10.1136/heartjnl-2016-311144. Epub 2017 Jun 29.

40.

Outcome of cardiac surgery in patients with congenital heart disease in England between 1997 and 2015.

Kempny A, Dimopoulos K, Uebing A, Diller GP, Rosendahl U, Belitsis G, Gatzoulis MA, Wort SJ.

PLoS One. 2017 Jun 19;12(6):e0178963. doi: 10.1371/journal.pone.0178963. eCollection 2017.

41.

Year in review 2016: Interstitial lung disease, pulmonary vascular disease, pulmonary function, paediatric lung disease, cystic fibrosis and sleep.

Jee AS, Corte TJ, Wort SJ, Eves ND, Wainwright CE, Piper A.

Respirology. 2017 Jul;22(5):1022-1034. doi: 10.1111/resp.13080. Epub 2017 May 25. Review. No abstract available.

PMID:
28544189
42.

Chemical and biological assessment of metal organic frameworks (MOFs) in pulmonary cells and in an acute in vivo model: relevance to pulmonary arterial hypertension therapy.

Mohamed NA, Davies RP, Lickiss PD, Ahmetaj-Shala B, Reed DM, Gashaw HH, Saleem H, Freeman GR, George PM, Wort SJ, Morales-Cano D, Barreira B, Tetley TD, Chester AH, Yacoub MH, Kirkby NS, Moreno L, Mitchell JA.

Pulm Circ. 2017 Jul-Sep;7(3):643-653. doi: 10.1177/2045893217710224. Epub 2017 Jun 27.

43.

Pulmonary hypertension in ARDS: inflammation matters!

Price LC, Wort SJ.

Thorax. 2017 May;72(5):396-397. doi: 10.1136/thoraxjnl-2016-209199. Epub 2017 Feb 23. No abstract available.

PMID:
28232508
44.

Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry.

Sithamparanathan S, Nair A, Thirugnanasothy L, Coghlan JG, Condliffe R, Dimopoulos K, Elliot CA, Fisher AJ, Gaine S, Gibbs JSR, Gatzoulis MA, E Handler C, Howard LS, Johnson M, Kiely DG, Lordan JL, Peacock AJ, Pepke-Zaba J, Schreiber BE, Sheares KKK, Wort SJ, Corris PA; National Pulmonary Hypertension Service Research Collaboration of the United Kingdom and Ireland.

J Heart Lung Transplant. 2017 Jul;36(7):770-779. doi: 10.1016/j.healun.2016.12.014. Epub 2016 Dec 31.

PMID:
28190786
45.

Cardiac remodelling amongst adults with various aetiologies of pulmonary arterial hypertension including Eisenmenger syndrome-implications on survival and the role of right ventricular transverse strain.

Moceri P, Bouvier P, Baudouy D, Dimopoulos K, Cerboni P, Wort SJ, Doyen D, Schouver ED, Gibelin P, Senior R, Gatzoulis MA, Ferrari E, Li W.

Eur Heart J Cardiovasc Imaging. 2017 Nov 1;18(11):1262-1270. doi: 10.1093/ehjci/jew277.

PMID:
28011668
46.

Predictors of Death in Contemporary Adult Patients With Eisenmenger Syndrome: A Multicenter Study.

Kempny A, Hjortshøj CS, Gu H, Li W, Opotowsky AR, Landzberg MJ, Jensen AS, Søndergaard L, Estensen ME, Thilén U, Budts W, Mulder BJ, Blok I, Tomkiewicz-Pająk L, Szostek K, D'Alto M, Scognamiglio G, Prokšelj K, Diller GP, Dimopoulos K, Wort SJ, Gatzoulis MA.

Circulation. 2017 Apr 11;135(15):1432-1440. doi: 10.1161/CIRCULATIONAHA.116.023033. Epub 2016 Dec 15.

47.

Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension.

Rhodes CJ, Ghataorhe P, Wharton J, Rue-Albrecht KC, Hadinnapola C, Watson G, Bleda M, Haimel M, Coghlan G, Corris PA, Howard LS, Kiely DG, Peacock AJ, Pepke-Zaba J, Toshner MR, Wort SJ, Gibbs JS, Lawrie A, Gräf S, Morrell NW, Wilkins MR.

Circulation. 2017 Jan 31;135(5):460-475. doi: 10.1161/CIRCULATIONAHA.116.024602. Epub 2016 Nov 21.

48.

Bromodomain and extra-terminal protein mimic JQ1 decreases inflammation in human vascular endothelial cells: Implications for pulmonary arterial hypertension.

Mumby S, Gambaryan N, Meng C, Perros F, Humbert M, Wort SJ, Adcock IM.

Respirology. 2017 Jan;22(1):157-164. doi: 10.1111/resp.12872. Epub 2016 Aug 18.

49.

Pulmonary tumour thrombotic microangiopathy.

Price LC, Wells AU, Wort SJ.

Curr Opin Pulm Med. 2016 Sep;22(5):421-8. doi: 10.1097/MCP.0000000000000297. Review.

50.

Central pulmonary arteries in idiopathic pulmonary fibrosis: size really matters.

Price LC, Devaraj A, Wort SJ.

Eur Respir J. 2016 May;47(5):1318-20. doi: 10.1183/13993003.00272-2016. No abstract available.

Supplemental Content

Support Center